In this paper, we discuss the characteristics of GPCRs that make it so difficult to develop effective anti-GPCR antibodies. We then discuss Multispan’s customized MULTISCREEN GPCR FACS binding and functional assays for antibody profiling.
Multispan’s panel of GPCR orthologs can enable critical assessment of species-specific variations in target binding activity and modulation of GPCR signaling that could impact in vivo efficacy in small and large animal models.
For GPCR Compound Profiling and Drug Repurposing
How mutagenesis enables understanding structure/function relationships of GPCRs. Read full article.
With over 16 years of in vitro safety pharmacology experience, Multispan leads the way in providing researchers with the tools needed… Read full article.
Assay Orphan GPCRs in High Throughput with MultiScreen Beta-Arrestin Sensor Technology. Read and download full article.
Hit-to-Lead and Lead Optimization In Vitro Pharmacology Support. Saving time, energy and cost from target-to-IND. Read and download full article.
2020 was a banner year for CXCR7. Two research studies and several great review articles were published that delve into the biased nature of CXCR7 signaling, its role in cancer, and the development of CXCR7-selective inhibitors.
CRISPR Breaks into GPCR Research Again Delineating the Role of GRK2/3 in Opioid Receptor Internalization. Read full scientific insight. View all scientific insights.
The foundational role of relevant, robust cell-based assays in covid antiviral and vaccine development.
Harness the power of freeing your GPCR from unwanted tags using Multispan’s proprietary MultiScreen™ β-Arrestin sensor technology.
The Power of Integrating Screening and Assay Development.
Explore the many types of ligand binding assays using GPCR membranes and the importance of high-quality membranes for assay development.
CRISPR cell engineering solutions have seamless integration into Multispan’s full assay development, screening and profiling services for drug discovery.
